Categorie -wet- en regelgeving

bv CGR, GDPR

FDA approves Pfizer & Astellas' Xtandi for earlier prostate cancer treatment setting

wet- en regelgeving

US FDA approves Pfizer & Astellas’ Xtandi for earlier prostate cancer treatment setting

20 november 2023

Pharma Biz

Takeda's enzyme replacement therapy approved by FDA for rare blood clotting disorder

wet- en regelgeving

Takeda’s enzyme replacement therapy approved by FDA for rare blood clotting disorder

14 november 2023

PMLiVE

Five things for pharma marketers to know:

wet- en regelgeving

Five things for pharma marketers to know: Monday, November 13, 2023

13 november 2023

MMM - Medical Marketing and Media

wet- en regelgeving

Europese plannen medicijnwetgeving slecht voor gezondheid en innovatie

10 november 2023

Pharmamarketeer™

Five things for pharma marketers to know:

wet- en regelgeving

Five things for pharma marketers to know: Thursday, November 9, 2023

9 november 2023

MMM - Medical Marketing and Media

Phathom Pharma's vonoprazan tablets gets US FDA approval for treatment of erosive esophagitis

wet- en regelgeving

Phathom Pharma’s vonoprazan tablets gets US FDA approval for treatment of erosive esophagitis

3 november 2023

Pharma Biz

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer